Tor‐Kristian Jenssen
Papers
1
Total Citations
57
H-Index
1
About
Tor‐Kristian Jenssen is a prominent researcher in the fields of hematopathology and molecular oncology, with a particular focus on B-cell lymphomas and their transcriptional regulation. His major contributions center on elucidating the molecular mechanisms underlying splenic marginal zone lymphoma (SMZL), a rare B-cell malignancy. In his seminal 2004 study, Jenssen demonstrated the constitutive expression of AP-1 transcription factors—including c-jun, junD, junB, and c-fos—alongside the marginal zone B-cell transcription factor Notch2 in SMZL, providing critical insights into the aberrant signaling pathways driving this disease. This work, cited 57 times, has been foundational for understanding the transcriptional landscape of SMZL and has implications for targeted therapeutic strategies. Jenssen’s research bridges basic molecular biology and clinical pathology, offering a deeper understanding of lymphoma pathogenesis. His achievements include advancing the characterization of SMZL, which has informed diagnostic criteria and potential biomarkers. For students and researchers, Jenssen’s work exemplifies how dissecting transcription factor networks can reveal disease mechanisms and open avenues for precision medicine in hematologic cancers.
Research Focus
Key Achievements
Top Papers
- 1